Search results for: 'mexico medtech outlook forecast to 2026'

Frost & Sullivan’s Medtech and Imaging programs explore, articulate, and address the medical industry’s most pressing questions related to growth. The programs focus on core segments such as care delivery, care management, imaging informatics, intelligent imaging, and business models. They independently review and identify companies that are produc...

09 Apr 2024  |  North America  |  Market Research

Global Medtech Outlook, 2024

New Product Development and Approvals Drive Industry Growth Opportunities

Infographics

×

The Global MedTech Outlook, 2024 presents a comprehensive analysis of the global MedTech industry in terms of growth potential and important market dynamics. The analysis covers major MedTech segments such as cardiovascular, orthopedics, patient monitoring, respiratory devices, neurology, diabetes care, and clinical-grade wearables. It highlights k...

The report analyzes the Mexican MedTech market, including a forecast analysis on key market segments, such as cardiovascular devices, drug delivery devices, hospital supplies, patient monitoring devices, urology-gynecology devices, and robotics. The Mexican MedTech market grew steadily in 2023, mainly because of an increasing aging population a...

This Frost & Sullivan study focuses on sustainability in the MedTech industry and offers a detailed discussion on 2 sustainability programs, Climate Action and Responsible Consumption and Production. The study's focus areas include key regulations in the EU, such as the EUDAMED database and green taxonomy and ESG in the United States and Asia-Pacif...

This study focuses on the top 10 strategic imperatives impacting the MedTech industry in 2025. The industry includes the medical devices and medical imaging and informatics markets. Top transformations impacting industry growth include competitive intensity, compression of the value chain, industry convergence, transformative megatrends, internal...

05 Sep 2024  |  Global  |  Technology Research

R&D Investment Analysis of the Medtech Sector

Artificial Intelligence Integration and Medical Devices Miniaturization to Drive Transformational Growth

Infographics

×

Before the COVID-19 pandemic, medical technology (medtech) registered significant investment in R&D. However, the investment trend declined post-pandemic but is gradually picking up momentum. Top medtech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for medt...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

While the United States and Europe medical device markets face backlash from the economic slowdown, the Russia-Ukraine war, and the cost-of-living crisis, the APAC medical devices market continues to record phenomenal growth. However, 2023 will be challenging for APAC medtech due to uncertainties arising from the anticipated market slowdown and oth...

The global distribution infrastructure and delivery market is entering a state of hyper-transformation in 2026. This market, which serves as the foundational architecture for the digital economy, has moved beyond the simple, high-speed movement of packets to become the primary orchestrator of digital trust, sovereign data residency, and autonomous ...